Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Glen R. Anderson | 10% Owner | 2023-08-14 | 23,934 | $2.34 | $56.01kBuy |
Glen R. Anderson | 10% Owner | 2023-08-11 | 35,064 | $2.12 | $74.34kBuy |
Glen R. Anderson | 10% Owner | 2023-08-10 | 44,354 | $1.94 | $86.05kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Dexcel Pharma Technologies Ltd | 49.60% | 4,234,897 | $10.33M | Insider |
Michael James Newman | 16.02% | 1,368,356 | $3.34M | Insider |
Glen R. Anderson | 15.28% | 1,304,318 | $3.18M | Insider |
Vanguard Group Inc | 3.00% | 256,265 | $625.29k | Institution |
John W. Kozarich | 1.78% | 151,761 | $370.30k | Insider |
Investment House LLC | 1.20% | 102,437 | $249.95k | Institution |
Jeffrey A. Meckler | 0.88% | 75,374 | $183.91k | Insider |
Geode Capital Management LLC | 0.64% | 54,767 | $133.63k | Institution |
Anthony J. Maddaluna | 0.63% | 53,570 | $130.71k | Insider |
Strategy Asset Managers LLC | 0.53% | 45,336 | $110.62k | Institution |